Catalera Gets $98.4K for Canadian Seed-Treatment Trials

Handling a seed can change how much biological material reaches the field. Catalera BioSolutions is building a delivery business around that journey, using plant-derived wax particles to carry and protect biological ingredients. New Canadian support will help the Vancouver company examine how its seed-coating technology performs under local agronomic conditions.

Natural Products Canada announced a CAD137,989 Proof of Concept contribution on October 22, 2026, toward a CAD344,972 project. Those amounts are approximately $98.4K and $246K, respectively, using the Bank of Canada's October 22 exchange rate. The work will generate field data to assess technical performance and commercialization readiness, putting a specific evidence assignment behind a funding headline that rounds the contribution to CAD138K.

What the Canadian funding will support

The original NPC announcement identifies Catalera's project as validation of a natural wax-based microencapsulation platform for biological seed treatments. The contribution accounts for approximately 40% of the stated project budget. The release leaves the field sites, crop selection and testing timetable unspecified, so the project should be understood through its stated purpose rather than an assumed trial protocol.

NPC describes its commercialization programs as non-dilutive support, generally non-repayable subject to contractual conditions. For a supplier selling an agricultural technology, that form of financing can put money toward an expensive part of a customer conversation: producing evidence under the conditions in which the customer expects to use the product. Catalera's award is attached to that work, with technical performance and commercial readiness as the announced objectives.

The distinction between contribution and project budget also matters. CAD344,972 describes the total activity being supported; CAD137,989 is NPC's contribution. Keeping the amounts separate gives readers a clearer view of the scale of the undertaking without turning the full project cost into newly raised capital or treating a funding announcement as confirmation that all money has already been disbursed.

Why a biological delivery supplier studies the planter

Catalera calls its patented microparticle technology CeraTek. In seed applications, the company describes biodegradable, plant-derived wax particles that combine seed flowability with delivery of biological ingredients to the seed surface. Its broader platform also addresses foliar and fertilizer applications, giving the same delivery business several places to work inside an agricultural input portfolio.

The commercial proposition includes integration. Catalera says it works with biological-input companies, seed businesses and crop-protection suppliers, beginning with prototyping around a partner's active ingredient and target application, then moving toward scale-up and commercial supply. A delivery specialist in that position has to help another supplier make a product useful. Performance must survive the handling between formulation and application, while the finished input still has to fit the equipment and work around it.

A separate 2026 trial-recruitment notice from INTENT makes the equipment assignment concrete. INTENT sought Midwest corn and soy farmers for a split-field comparison of Catalera's seed fluency agent against standard talc/graphite, collecting planting measurements including spacing, skips, doubles and singulation. That notice describes US trial design, rather than results or the newly funded Canadian project. It shows why a biological-delivery company's evidence can include the planter's work as well as the material carried on a seed.

The evidence already available, and its limits

Catalera's own technology case study reports 4.5x more microbe delivered to soybean seed after mechanical agitation in a Trichoderma comparison. The measure concerns retention through handling, which fits the company's focus on getting biological ingredients to their destination. It should be read as a company-reported result for that comparison, with its meaning tied to the experiment described.

Microbial retention and crop yield answer different questions. The case study supplies information about delivery; the newly announced Canadian project is intended to examine field performance and commercialization readiness. Buyers need to understand which measurement supports which claim, particularly when a product moves from a controlled comparison into a grower's operating conditions.

Catalera also says CeraTek-based products, including a seed-fluency replacement for talc/graphite, are already commercially available. The new project therefore sits within an existing delivery platform and commercial offering. For a prospective partner, the practical conversation is about the particular active ingredient, application and conditions being evaluated, alongside how the delivery material fits an established product line. More local data can make that discussion more specific without requiring a claim that every biological input behaves the same way.

Venture backing meets a Canadian field assignment

Catalera became an independent company through a Terramera spinout in 2024. S2G Investments' company profile identifies Matthew Dahabieh as CEO and Vancouver as its headquarters. Catalera's current leadership page also lists Mike Allan as CCO, Inha Park as VP Finance and Gabe Lee as VP Product & Regulatory, a team spanning the commercial and operating work around the technology.

The earlier financing needs its own accounting. Transaction counsel Fasken records a $6.5M initial Series A close in June 2024. Farm Credit Canada's September announcement described an $8M round led by S2G Ventures, with FCC Capital participating and a second and final close expected later that year. Those records establish historical backing while describing different close states; they do not supply a verified current total for all of Catalera's financing.

The latest NPC contribution brings the story back to the field. An input company considering wax-based delivery has to decide where the technology belongs in its portfolio, and a grower has to use the resulting product during a planting season. Catalera's Canadian project will produce evidence for those decisions in the agronomic conditions named in the award, carrying the delivery business from the seed coating into the work of choosing what gets planted.